Comunicati Stampa
Salute e Benessere

PHARMANUTRA S.P.A.: DISTRIBUTION AGREEMENT FOR SIDERAL® PRODUCTS SIGNED IN CANADA

The contract has been signed with the Canadian pharmaceutical company Sigma Lifesciences, which is active in the production and distribution of health products, for the sale of four products in Canada, adding to the over 80 countries where the company founded in 2003 by Andrea and Roberto Lacorte is already present. The contract has been signed with the Canadian pharmaceutical company Sigma Lifesciences, which is active in the production and distribution of health products, for the sale of four...
North America, (informazione.it - comunicati stampa - salute e benessere)

The contract has been signed with the Canadian pharmaceutical company Sigma Lifesciences, which is active in the production and distribution of health products, for the sale of four products in Canada , adding to the over 80 countries where the company founded in 2003 by Andrea and Roberto Lacorte is already present.

Specifically, Sigma Lifesciences will handle the distribution in Canada of SiderAL® Forte, SiderAL® Folic, and SiderAL® Drops, dietary supplements based on Sucrosomial® Iron, developed using the patented Sucrosomial® Technology, an innovative delivery system that protects the molecules of micronutrients like iron, enhancing absorption and improving tolerability.

As part of the marketing plan for SiderAL® products, scheduled for the second quarter of 2025 with the launch of SiderAL® Forte, SiderAL® Folic, and SiderAL® Drops,a training session for the Sigma Lifesciences team was held last week in Toronto , conducted by the Scientific and Commercial Management of PharmaNutra. During this event, one Focus Groups took place with more than thirty Canadian pharmacists and doctors from various therapeutic areas – Gynecology, Hematology, Internal Medicine and Oncology – aimed at developing the knowledge of Sucrosomial® Technology and understanding the specific needs of the local market.

In addition to the three SiderAL® products – leaders in the market for oral iron products in many countries – Ultramag®, a dietary supplement based on Sucrosomial® Magnesium, will also be part of Sigma Lifesciences' product portfolio.

Either Ultramag® and the SiderAL® products - Forte, Folic, and Drops - have received official registration from Health Canada for commercialization in the country.

 

CONTACT:
Investor Relations Pharmanutra , 050 7846500, investorrelation@pharmanutra.it
Emanuel Richelmy, Pharmanutra,  +39 391 7310645, emrichel@gmail.com
Cristina Tronconi , +39 346 0477901, ctronconi@sprianocommunication.com
Matteo Russo , +39 347 9834881, mrusso@sprianocommunication.com

View original content: https://www.prnewswire.co.uk/news-releases/pharmanutra-spa-distribution-agreement-for-sideral-products-signed-in-canada-302315295.html

Ufficio Stampa
 PR Newswire (Leggi tutti i comunicati)
209 - 215 Blackfriars Road
LONDON United Kingdom
Allegati
Non disponibili